… for seronegative patients and controls, the second dose was required for maximum response
at day 69, which was lower in seronegative patients than in seronegative controls. GMTs in …

… in asymptomatic SARS-CoV-2 seropositive and highly exposed seronegative individuals …
controls defined as samples from seronegative individuals without any contact to SARS-CoV…

… The study design was a cross-sectional serological survey with a nested case-control study.
… Seropositive donors and a control group of seronegative donors were questioned about …

… , seronegative volunteers with a pre-Alpha severe acute respiratory syndrome coronavirus 2
(SARS-CoV-… modeling of immune responses to primary SARS-CoV-2 infection that revealed …

… links with virus neutralization of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2),
we evaluated individuals for SARS-CoV-2 antibody level and viral neutralization. …

… in the hazard of being infected among participants with antibodies against SARS-CoV-2,
when compared to seronegative controls, >8 months after initial serology assessment. …

… Using the positive control beads, we determined the inter-assay (… Positive control beads
were utilized to ensure positive … binding by using the negative control samples MFI (beads …

… The frequency of SARS-CoV-2 infection (as determined by virus RNA detection) was
evaluated in a group of 1,460 seropositive and a control group of 8,150 seronegative healthcare …

… assays for retrospective diagnosis of SARS-CoV-2, we decided to use a robust SARS-CoV-2
T cell … For positive controls, we used PBMC samples from a cohort of patients with RT-qPCR …

… ), would expand in vivo to support rapid viral control, aborting infection. We measured … We
provide T cell and innate transcript evidence for abortive, seronegative SARS-CoV-2 infection. …